Whitepaper: BioFire® mycoplasma solution: results in one hour, fully automated detection system
Posted: 25 June 2020 | bioMérieux | No comments yet
In this whitepaper, bioMérieux describe the potential application of BioFire® FilmArray technology – a well-recognised technology used in infectious disease diagnostics – for rapid at-line detection of mycoplasmas in the pharmaceutical industry.
Routine testing for microbial contaminants is critically required in biopharmaceutical manufacturing to maintain control over product quality, safety and efficacy. In this whitepaper, we describe the potential application of BioFire®
FilmArray technology – a well-recognised technology used in infectious disease diagnostics – for rapid at-line detection of mycoplasmas in the pharmaceutical industry.1
Related content from this organisation
- The future of CMC for novel therapies
- Essential requirements for autologous cellular therapies
- Bioprocessing/Bioproduction In-Depth Focus 2022
- Application note: BIOBALL® Burkholderia cepacia complex strains performance testing for USP <60> growth promotion requirements
- Product hub: 3P® connect EM-BODY connectivity
Issue
Related topics
Cell culture automation, Manufacturing, Rapid Microbiological Methods (RMMs), Technology